These success, together with a former report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 support the thought of targeting ACKR3 as a unique way to modulate the opioid technique, which could open up new therapeutic avenues for opioid-relevant Diseases. Disclaimer: The above mentioned is https://conolidine53885.bloggazzo.com/31863579/5-simple-statements-about-conolidine-explained